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Abstract:  FTY720, a   novel  immunosuppressant,  has  a  marked  activity  in  decreasing 
peripheral blood T lymphocytes upon oral administration. Recent investigations suggest 
that  the  action  of  FTY720  on  lymphocytes  may  result  from  its  ability  to  induce  cell 
apoptosis. However, the cell signaling mechanism involved in the FTY720-induced cell 
apoptosis remains unclear. Here we examined the apoptotic signal pathways mediated by 
FTY720 in Jurkat cells using microarray analysis. The results showed that FTY720 can 
induce Jurkat cell apoptosis in a dose and time dependent manner as assessed by cell 
viability, Hoechst 33258 staining, Annexin V binding and DNA fragmentation tests. cDNA 
microarray analysis showed that 10 !M of FTY720 up-regulated 54 and down-regulated 10 
genes in Jurkat cells among the 458 apoptotic genes examined following the 6 h incubation 
period. At least five-fold increased expression of modulator of apoptosis-1 (MOAP-1), 
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vascular  endothelial  growth  factor  (VEGF),  tumor  necrosis  factor  receptor-associated 
factors (TRAF 6), Caspase 2 (CASP 2), E2F transcription factor 1 (E2F 1) and Casapse 5   
(CASP 5) genes was observed in microarray analyses; these results were confirmed with 
reverse  transcription  polymerase  chain  reaction  (RT-PCR)  examination.  Our  findings 
suggest that the mitochondria related signaling pathways are the key pathways involved in 
the FTY720-induced apoptosis in Jurkat cells. And our results provide a new insight into 
the mechanism of FTY720, which allows us to draw the first simple diagram showing the 
potential pathways mediated by FTY720. 
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1. Introduction 
The  novel  immunosuppressant  FTY720,  2-amino-2-[2-(4-octylphenyl)  ethyl]-1,3-propane-diol 
hydrochloride,  is  a  synthetic  compound  that  is  chemically  modified  from  ISP-1 
((2S,3R,4R)-(E)-2-amino-3,4-dihydroxy-2-hydroxymethyl-14-oxoeicos-6-enoic acid), a metabolite of 
the fungus Isaria sinclair ii [1]. It has been reported that FTY720 exhibits strong immunosuppressive 
activity  in  animal  models  of  transplantation  [2]  and  autoimmunity  [3]  without  causing  severe   
adverse reaction.   
A striking feature of FTY720 is the induction of a marked decrease in the number of circulating 
lymphocytes and inhibition of lymphocyte influx into inflammatory sites [4]. Unlike conventional 
immunosuppressants, FTY720 does not impair the activation or proliferative functions of T cells and B 
cells [5]. It is believed that the powerful immunosuppressive activity of FTY720 is related to the 
significant decrease in the number of blood T lymphocytes upon oral administration. However, the 
mechanism for the decrease in lymphocytes induced by FTY720 is not well understood. At present, 
two reports attract most attention on the issue. Chiba et al. have demonstrated that the decrease in 
blood lymphocytes was mainly caused by FTY720-induced sequestration of lymphocytes into lymph 
nodes and Peyer’s patches [6]. However, Luo et al. reported that administration of FTY720 to aly/aly 
mice, which lack lymph nodes and Peyer’s patches, decreased the peripheral T lymphocytes in the 
same  manner  as  in  normal  mice  [7].  In  addition,  administration  of  FTY720  to  C–C  chemokine   
receptor 7 (CCR-7) knockout mice also induced a marked decrease of peripheral T lymphocytes [8]. 
These results indicate that some other mechanisms are likely to be involved in the immunosuppressive 
effect of FTY720. Several reports have showed that oral administration of FTY720 selectively induces 
apoptosis of mature peripheral blood T cells or cancer cells in animal models of organ transplantation 
and  cancer,  resulting  in  a  marked  decrease  in  the  number  of  blood  lymphocytes  or  cancer  cells 
[2,9–11]. Furthermore, the ability of FTY720 to induce apoptosis in normal lymphocytes and cancer 
cells in vitro has been investigated [12–14]. FTY720-induced apoptosis appeared to be related to the 
activation  of  caspase  cascade  [15],  bcl-associated  signaling  [16,17]  independent  of  Fas  [18], 
phospholipase C [14]
 and protein kinases [12]. In order to better understand the potential apoptotic 
pathways induced by FTY720, we analyzed apoptotic signaling genes in the present study.   
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It  has  been  recognized  that  FTY720-induced  cells  apoptosis  mostly  focused  on  single  gene 
expression. Because apoptosis is a complicated biological process involving a large number of genes, 
it  is  necessary  to  investigate  FTY720-related  apoptotic  signaling  genes  as  a  whole  in  a  defined 
experimental  system.  Microarray  analysis  has  been  used  extensively  for  simultaneous  analysis  of 
transcript levels of thousands of genes in different physiological states of an organism, tissue, or cell 
over the last decade [19–21]. Such analyses have helped to identify numerous functional genes in 
many different cell types. We therefore employed the microarray technique in the present study to 
examine the signaling mechanism involved in FTY720-induced apoptosis in a human lymphoid T cell 
line, Jurkat cells.   
2. Results and Discussion 
2.1. FTY720 Reduces Cell Viability   
Jurkat cells were incubated with and without FTY720 at concentrations between 2 and 10 !M for 
12, 18 and 24 h, respectively, and the cell viability was then assessed by Methyl thiazol tetrazolium (MTT) 
assay (Figure 1). It was observed that the cell viability was markedly reduced in a dose dependent 
manner starting from 4 !M of FTY720. At a dose of 10 !M, FTY720 eliminated cell viability by 
88–90% after treatment for 24 h. FTY720 also showed a time-dependent reduction of Jurkat cell 
viability with the maximum reduction observed at 24 h after incubation (Figure 1). 
Figure 1. The effect of FTY720 on viability of Jurkat cells. Jurkat cells were incubated 
with  various  concentrations  of  FTY720  for  12,  18  and  24  h.  MTT  assay  showed  that 
FTY720 treatment caused a dramatic decrease in the viability of Jurkat cells in a dose– and 
time–dependent  manner.  The  results  are  presented  as  the  percentage  reduction  of c e l l  
viability  in  comparison  to  untreated  cells.  Data  are  expressed  as  mean  ± S .D.  of   
3 independent experiments performed in duplicate. * P < 0.05, ** P < 0.01 versus the 
absorbance of untreated cells. 
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2.2. FTY720 Induces Cell Apoptosis in Jurkat Cells   
The typical apoptotic morphological changes such as condensed chromatin and shrunken, crimpled 
and condensed gray-blue nuclei were found in the FTY720-treated Jurkat cells after staining with 
Hoechst 33258. FTY720-induced apoptosis of Jurkat cells occurred at 2 h following incubation and 
became more apparent at 4 and 6 h. FTY720 induced apoptosis was dose-dependent, with the most 
apparent  stain  occurring  after  the  addition  of  10  !M  FTY720  for  6  h  (Figure  2A).  Quantitative 
determination of FTY720 induced Jurkat cell apoptosis was performed by using Annexin V and PI 
staining. FTY720 induced a dose- and time-dependent apoptosis of Jurkat cells with up to 60.1% 
apoptotic  cells  observed  following  incubation  with  10  !M  FTY720  for  6  h  (Figure  2B). A  
dose-dependent  DNA  fragmentation  (DNA  ladder  formation)  was  observed  by  agarose  gel 
electrophoresis following incubation of 0 to 10 !M FTY720 with Jurkat cells for 6 h. FTY720 induced 
DNA fragmentation was also time-dependent, with the most apparent bands being observed at 6 h 
following incubation with 10 !M FTY720 (Figure 2C). 
Figure 2. Detection of apoptosis of Jurkat cells induced by FTY720. (A) Jurkat cells were 
incubated with various concentrations of FTY720 for 2, 4 and 6 h before being stained 
with Hoechst 33258. Magnification = "400. (B) Jurkat cells were incubated with various 
concentrations  of  FTY720  for  3  and  6  h  before  being  stained  with  Annexin  V/PI  and 
analyzed  by  flow  cytometry.  (C)  Agarose  gel  electrophoresis  for  DNA  fragmentation 
(DNA ladder formation) in Jurkat cells induced by FTY720. a: Jurkat cells were incubated 
with various concentrations of FTY720 for 6 h; b: Jurkat cells were incubated with 10 !M 
FTY720 for 0, 1, 2, 4 and 6 h. 
 
 
     
     
 
 
 
 
0 !M 
6 h  2 h  4 h 
2 !M 
A Int. J. Mol. Sci. 2010, 11                         
 
3091 
Figure 2. Cont. 
     
     
     
     
 
 
 
 
 
4 !M 
6 !M 
8 !M 
10 !M 
B Int. J. Mol. Sci. 2010, 11                         
 
3092 
Figure 2. Cont. 
 
 
3 h  6 h Int. J. Mol. Sci. 2010, 11                         
 
3093 
Figure 2. Cont. 
 
     
 
2.3. Microarray Analysis 
In order to obtain a comprehensive picture of the transcriptional changes caused by FTY720, total 
RNA from Jurkat cells (treated with 10 !M FTY720 for 6 h) was extracted for microarray analysis. 
The results showed that the expression of 64 genes (out of the 458 genes) was significantly altered by 
the presence of FTY720 in the Jurkat cells, among which 54 genes were up-regulated and 10 genes 
were down-regulated (Table 2). The scatter plot showed that the gene expression levels of FTY720 
treated cells and untreated cells seemed to have a linear relationship, and the linear correlation between 
these two variables was 0.967 (Figure 3). 
Table  2.  List of the apoptosis related genes that were significantly altered by FTY720 
treatment in Jurkat cells. Total RNA from Jurkat cells treated with 10 !M FTY720 for 6 h was 
extracted  for  microarray  analysis.  Representative g e n e s  w e r e  s i g n i f i c a n t l y  u p -regulated  (3-fold 
change) and down-regulated (2-fold change) by FTY720 in Jurkat cells (out of 64 significantly 
regulated genes by FTY720 in Jurkat cells in microarray analysis). 
Gene 
symbol 
Gene name 
Fold 
change 
P value 
Pro-apoptosis genes 
MOAP1  Modulator of apoptosis 1  10.91  8.53E-10 
VEGF  Vascular endothelial growth factor  7.72  4.01E-05 
TRAF6  TNF receptor-associated factor 6  6.93  1.31E-05 
CASP2 
Caspase 2, apoptosis-related cysteine protease (neural 
precursor cell expressed, developmentally down regulated 2) 
5.82  8.93E-10 
E2F1  E2F transcription factor 1  5.68  1.25E-06 
CASP5  Caspase 5, apoptosis-related cysteine protease  5.06  1.17E-05 
a  b 
C  M     0      4     6    8   10 (!M)  M   0     1    2    4    6 (h) Int. J. Mol. Sci. 2010, 11                         
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Table 2. Cont. 
Gene 
symbol 
Gene name 
Fold 
change 
P value 
Mdm4 
Mdm4, transformed 3T3 cell double minute 4, p53 binding 
protein (mouse) 
4.72  0.00011 
BAX  BCL2-associated X protein  4.38  3.73E-05 
BNIP3L  BCL2/adenovirus E1B 19kD interacting protein 3-like  4.18  0.00014 
LTA  Lymphotoxin alpha (TNF superfamily, member 1)  3.64  8.12E-05 
TUCAN 
Tumor  up-regulated  CARD  -containing  antagonist  of 
caspase 9 
3.01  8.11E-07 
Anti-apoptosis genes 
IGF2  Insulin-like growth factor 2 (somatomedin A)  6.17  1.81E-05 
JUN (AP-1)  V-jun sarcoma virus 17 oncogene homolog (avian)  4.83  0.00017 
BIRC1  Baculoviral IAP repeat-containing 1  4.07  6.0E-09 
FKSG2  Apoptosis inhibitor  3.71  9.85E-08 
BCL2  B-cell CLL/lymphoma 2  0.45  0.000377 
RAD23B  RAD23 homolog B (S. cerevisiae)  0.48  0.000135 
 
Figure  3.  Scatter  plot  for  the  correlation  of  gene  expression  levels  between  FTY720 
treated  cells  and  untreated  cells.  The  Cy3  (treated  group)  and  Cy5  (untreated  control) 
channel intensities from the two-color DNA microarray experiments were showed in the 
scatter plot. Variables appear a linear relationship, and the linear correlation between them   
is 0.967. 
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2.4. Validation of Microarray Data with RT-PCR and Western Blotting   
To validate the microarray results, six genes including MOAP-1, VEGF, TRAF 6, CASP 2, E2F 1 
and  CASP  5  were  chosen  from  the  top  of  Table  2  as  representatives  of  pro-apoptosis  genes  for 
RT-PCR analysis. The results showed that the mRNAs of all six selected genes were significantly 
up-regulated in FTY720 treated cells (Figure 4A). The levels of the selected gene expression (fold 
increase) were well matched between microarray and RT-PCR analyses (Figure 4B). To confirm the 
increase in MOAP-1 and VEGF expression at the protein level, Western blotting experiment was 
conducted  (Figure  5A).  Approximately  2.2  and  1.7  fold  increase  in  MOAP-1  and  VEGF  protein 
expression was observed when Jurkat cells were treated with for 6 h (P < 0.05) (Figure 5B). 
Figure  4.  RT-PCR  analyses  of  mRNA  levels  of  six  selected  genes  MOAP-1,  VEGF, 
TRAF 6, CASP 2, E2F1 and CASP 5 in Jurkat cells and FTY720 treated Jurkat cells.   
(A) Representative gel electrophoresis of PCR products. (B) Comparison of the mRNA 
levels  of  six  selected  genes  detected  by  semi-quantitative  RT-PCR  to  those  from 
microarray data. The quantitation of the mRNA expression of the six genes is shown as the 
average ratio of band intensity to that of the internal control #–actin. Data are expressed as 
mean ± S.D. from three independent experiments. 
 
 
 
 
 
 
 
    
                      
 
 
 
 
 
 
 
 
 
 
A 
Control  FTY720 treated 
 
 
 
 
 
 
 
MOAP-1 (155 bp)   
 
VEGF (174 bp) 
 
TRAF 6 (242 bp) 
 
CASP 2 (304 bp) 
 
E2F1 (121 bp) 
 
CASP 5 (109 bp) 
 
"–actin (156 bp) 
 
 Int. J. Mol. Sci. 2010, 11                         
 
3096 
Figure. 4. Cont. 
 
 
Figure 5. Western blotting analyses of MOAP-1 and VEGF protein expression in Jurkat 
cells and FTY720 treated Jurkat cells. (A) Representative Western blot. (B) Quantitation of 
the protein levels of MOAP-1 and VEGF in cells was shown as the average ratio of band 
intensity to that of the internal control GAPDH. Data are expressed as mean ± S.D. from 
three independent experiments. * P < 0.05 versus normal control cells. 
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The ability of FTY720 to initiate apoptosis in some leukemia cell lines or cancer cells has been 
reported. However, the apoptotic signaling mechanism in lymphocytes remains obscure. The present 
study  examined  the  apoptotic s ignaling  pathways  with  microarray  analysis  technique  and  drew  a 
simplified diagram to show the potential signal transduction pathways mediated by FTY720.   
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Upregulation of expression of MOAP-1 and Bax by FTY720 has been observed in the present study, 
indicating that mitochondria related signaling pathways is likely to be involved in the FTY720-induced 
apoptotic process. MOAP-1 is a novel mitochondria enriched protein that associates with Bax upon 
stimulation. It facilitates translocation of Bax from cytosol to mitochondria which subsequently leads 
to the release of cytochrome c from the mitochondria [22]. It was found that up-regulation of MOAP-1 
is not a consequence of apoptosis, but an early event in the apoptotic signaling process [23]. However, 
one  study  showed  that  death  receptor  signaling  was  related  to  Bax  activation  through  binding  to 
MOAP-1 [24], suggesting activation of MOAP-1 may be associated with cellular events other than 
apoptosis. Furthermore, enhanced expression of Bax and down regulated expression of bcl-2 after 
FTY720 treatment caused a marked decrease in the ratio of bcl-2 to Bax in Jurkat cells, suggesting 
further the importance of Bax in the FTY720-induced apoptotic process. It has been reported that 
FTY720 decreased the ratio of bcl-2/Bax in the human lymphocytes [17], which may support our 
observation above. Recently it was reported that FTY720-induced apoptosis strongly correlated with 
the inhibition of sphingosine kinase (SK) in LLC-PK1 cells, and subsequently reduced production of 
sphingosine-1-phosphate  (S1P), a   suppressor  of  Bax  [25].  This  may  also  contribute  to 
FTY720-induced apoptosis in Jurkat cells. 
Significantly upregulated expression of Smac (second mitochondria-derived activator of caspase) 
by  FTY720  confirms  that  mitochondrial  signaling  pathways  are  key  pathways  involved  in  the 
FTY720-induced apoptotic process in Jurkat cells. Smac is a novel mitochondrial protein, which is 
released  into  the  cytosol  when  a  cell  undergo  apoptosis.  It  can  promote  apoptosis  by  binding  to 
inhibitor of apoptosis proteins (IAPs) and subsequently activating caspases [26]. Over expression of 
Smac has been found in some tumor cells including gastric cancer cells, lung cancer cells, ovarian 
cancer cells [27], our data are in line with those previous studies. Another element of mitochondrial 
signaling pathways Apaf-1 (apoptotic protease activating factor 1) was also overexpressed by Jurkat 
cells  in  response  to  FTY720.  Since  Apaf-1  has  been  found  to  participate  in  the  pathway  of 
mitochondria-mediated  apoptosis  [28],  it  may  be  involved  in  FTY720  induced  apoptosis  in   
Jurkat cells. 
Besides the genes in mitochondria related signaling pathways, some genes of the death receptor 
mediated apoptotic signal pathway such as tumor necrosis factor receptor superfamily member 10B 
(TNFRSF10B) and lymphotoxin alpha (LTA), and endoplasm mediated apoptotic signal pathway such 
as  calcium  channel  voltage-dependent  beta  2  subunit  (CACNB  2)  and  calcium  channel 
voltage-dependent  beta  3  subunit  (CACNB  3)  were  observed  to  be  upregulated  after  FTY720 
treatment, indicating that mitochondria apoptotic signal pathway is unlikely to be the only pathway 
involved  in  the  FTY720-induced  apoptosis.  Similarly,  genes  of  VEGF,  tumor  necrosis  factor 
receptor-associated factors (TRAF 6), transcription factor E2F 1 and caspase 5 were also found to be 
significantly  up-regulated  in  response  to  FTY720.  However,  it  is  rather  difficult  to  draw  a  clear 
conclusion for their involvement in FTY720-induced apoptotic signaling process in Jurkat cells. Int. J. Mol. Sci. 2010, 11                         
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3. Experimental Section 
3.1. Materials 
Jurkat cells were obtained from the ATCC Corporation (Manassas, VA, USA). EZ-10 column DNA 
mini-preps kit was purchased from Bio Basic Inc. (East Markham, Ontario, Canada). Annexin V-FITC 
Apoptosis Detection Kit I was from BD Biosciences (San Diego, CA, USA). BCA Protein Assay Kit 
was  from  Pierce  Endogen  (Rockford,  IL,  USA).  Rabbit  anti-human  modulator  of  apoptosis-1 
(MOAP-1) polyclonal antibody was purchased from ProSci Incorporated (Poway, CA, USA), rabbit 
anti-human  vascular  endothelial  growth  factor  (VEGF) p olyclonal  antibody  was  from  Santa  Cruz 
Biotechnology (Santa Cruz, CA, USA), and swine anti-rabbit IgG-HRP was from DakoCytomation 
(Produktionsvej, Glostrup, Denmark). Enhanced chemiluminescence reagent and Cy3 or Cy5-dUTP 
was purchased from Amersham Pharmcia Biotechnology (Piscataway, NJ, USA). Prestained protein 
marker  was  from  New  England  Biolabs  (Beverly,  MA,  USA). 
3-(4,5-dimethylthia-zol-2-yl)-2,5-diphenyl  tetrazolium  bromide  (MTT)  was  from  Bio  Basic  Inc. 
(Markham,  Ontario,  Canada).  RPMI  1640  medium, f e tal  bovine  serum  and  TRIzol  reagent  were 
purchased  from  Invitrogen  Life  Technologies ( Carlsbad,  CA,  USA).  FTY720  was  from  Cayman 
Chemical (Ann Arbor, MI, USA). Dimethyl sulfoxide and albumin bovine were from Amresco Inc. 
(Solon, Ohio, USA). Hoechst 33258 was from Sigma (St. Louis, MO, USA). RNeasy Mini Kit and 
QIAquick Nucleotide Removal kit were purchased from Qiagen (Hilden, Germany). TaKaRa High 
Fidelity RNA PCR Kit was purchased from TaKaRa Biotechnology (Dalian, China) and Taq PCR 
MasterMix was from Tiangen Biotech Co. (Beijing, China). The Human Apoptosis Microarray V 1.1 
was from National Engineering Center for Biochip (Shanghai, China). 
3.2. Cell Culture and FTY720 Treatment 
Jurkat  cells  were  grown  in  RPMI  1640  medium  supplemented  with  10%  fetal  bovine  serum, 
penicillin (100 U/mL), streptomycin (100 U/mL), and glutamine (2 mM) in 25-cm
2 tissue culture 
flasks at 37 °C in a 5% (v/v) CO2, water-saturated atmosphere. The cell viability was greater than 95% 
assessed  by  trypan  blue  staining.  The  medium  was  replaced  every  2  days,  and  the  cells  were  in 
logarithm phase for the experiments. FTY720 was dissolved in RPMI 1640 medium at concentrations 
ranging from 2 to 10 !M.   
3.3. Viability Assay by MTT 
The cells were resuspended in complete RPMI 1640 medium at a concentration of 5 ! 10
4 cell/mL. 
Cells (1 ! 10
4) were incubated in a 96-well flat-bottomed culture plate in 200 !L volumes with or 
without various concentrations (2 and 10 !M) of FTY720 for 12, 18 and 24 h, respectively, at 37 °C. 
Cell viability was assessed by MTT assay. Briefly, 20 !L of 5 mg/mL MTT was added to each well 
before the end of the FTY720 treatment, and incubated for a further 4 h. After incubation, the plates 
were centrifuged at 450 g for 5 min and the supernatants were discarded. Dimethyl sulfoxide (150 !L) 
was then added to each well for 10 min in the dark, followed by addition of formazan crystal solution. 
The absorbance was measured at 570 nm using an ELISA plate reader (Bio-Rad 680, USA).   Int. J. Mol. Sci. 2010, 11                         
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3.4.  Apoptosis  AssaysHoechst  33258  staining:  Cells  (5  !  10
5)  were  harvested  after  2,  4  and  6  h 
incubation period and centrifuged at 400 g for 5 min. After washing with cold phosphate-buffered 
saline  (PBS),  cells  were  fixed  in  50  !L  of  3%  polyformaldehyde  solution  for  10  min  at  room 
temperature, and then exposed to 15 !L of Hoechst 33258 in a final concentration of 16 !g/mL for 15 
min  in  the  dark.  After  washing,   
10 !L of cell pellet was dropped on a glass slide and the image was observed under a fluorescence 
microscope (Nikon TE2000, Japan). The apoptosis in Jurkat cells was determined by the alteration of 
nuclear morphology and fluorescent density observed after staining with Hoechst 33258.   
Flow cytometry analysis: Cells (1 ! 10
6) were harvested after 3 and 6 h incubation period and 
centrifuged at 450 g for 5 min at 4 °C. After washing twice with PBS, the cell pellet was suspended in 
100  !L  Annexin  V  binding  buffer.  Cells  were  incubated  with  5  !L  Annexin  V-FITC  and  5  !L 
propidium iodide (PI) for 15 min at room temperature away from light before addition of 400 !L 
Annexin  V  binding  buffer.  The  cell  pellet  was  analyzed  using  a  FACScan  flow  cytometer  (BD 
Biosciences, San Jose, CA). The early apoptotic cells (Annexin-FITC positive and PI negative) were 
located in the lower right quadrant. The late apoptotic or necrotic cells (Annexin-FITC positive and PI 
positive) were located in the upper right quadrant. Healthy cells (negative for both probes) were located 
in the lower left quadrant. The results are expressed as percentage of positively stained cells in total cells. 
DNA fragmentation: Cells (2 ! 10
6) were harvested after 0, 1, 2, 4 and 6 h and centrifuged at 450 g 
for 5 min at 4 °C. The DNA extraction and purification was performed using the EZ-10 column 
mini-preps kit according to the manufacture’s instruction. Briefly, cells were suspended in 800 !L 
TBP Buffer and centrifugated at 800 g for 3 min. The cells were then mixed with 500 !L TBM Buffer 
and 3 !L proteinase K at 55 °C for 30 min. After centrifugation at 1200 g for 2 min, a mixture of the 
cell supernatant with 260 !L absolute ethanol was applied to the EZ-10 column. This was followed by 
addition of 30 !L elution buffer (2.0 mM Tris-Hcl, PH 8.0) to the column and incubated at 50 °C for   
2 min. The column was spun at 2000 g for 1 min to elute DNA from the column. The DNA quantity 
was measured by UV absorption at A260 with a spectrophotometer (Beckman Coulter DU800, USA). 
DNA samples were electrophoresed on 2% agarose gels with SYBR Green I staining, and the bands 
were visualized by a Bio-Rad Gel Imaging System (Bio-Rad ChemiDoc XRS, USA). 
3.5. Microarray Analysis   
Cells (1 ! 10
7) were harvested 6 h after treatment with 10 !M FTY720, and centrifuged at 450 g for 
5 min at 4 °C. Total RNA was prepared using TRIzol reagent, further purified with an RNeasy Mini 
Kit. Approximately 2 !g of total RNA was reverse-transcribed, amplified and labeled with either   
Cy3 (treated group) or Cy5 (untreated control). Four micrograms of labeled cDNA was hybridized to 
Human Apoptosis Microarray V 1.1, which consists of 458 genes involved in apoptosis, including 
death receptors and their ligands, caspases, Bcl-2 gene family, calpains, death kinases, granzymes, 
DNA fragmentation proteins, and some other genes, according to the manufacture’s instruction. After 
washing, the arrays were scanned using the Agilent GeneArrayTM scanner system (Hewlett-Packard, 
USA).   
Three  independent  experiments  were  performed,  and  expression  signals  were  converted  into 
numerical data using the ImaGene software 5.5 (BioDiscovery Inc., CA, USA) and the raw data was Int. J. Mol. Sci. 2010, 11                         
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saved as a Microsoft Excel file. Data were subsequently exported to Genespring version 7.0 (Silicon 
Genetics, Redwood City, CA, USA) for background subtraction based on negative controls and per 
spot and per chip intensity dependent normalization (non-linear or LOWESS normalization). These 
corrected, normalized signals can then be used to estimate the relative abundance of genes with the 
ratio of Cy-3 and Cy-5 signal intensities. Changes in gene expression were considered significant if the 
detection P value was less than 0.05 in at least two of three arrays, and the fold change was at least 2.0. 
3.6. Semi-Quantitative RT-PCR Analysis 
Semi-quantitative  RT-PCR  analysis  was  used  to  confirm  expression  of  the  six  selected 
pro-apoptosis genes including MOAP-1, VEGF, TNF receptor-associated factor 6 (TRAF 6), caspase 2 
(CASP 2), E2F transcription factor 1 (E2F 1) and caspase 5 (CASP 5), which were up-regulated more 
than 5-fold following FTY720 treatment in Jurkat cells in the microarray analysis. Jurkat cells (6 ! 10
6) 
were harvested at 6 h after treatment with 10 !M FTY720 and total RNA was prepared with TRIzol 
reagent. The cDNA synthesis was performed with TaKaRa High Fidelity RNA PCR kit according to 
the manufacturer’s instruction: 5 !L of 2 ! Bca 1st buffer, 2 !L of MgSO4 (25 mM), 0.5 !L of dNTP 
mixture (10 mM), 0.25 !L of RNase inhibitor (40 U/!L), 0.5 !L of Bca PLUS RTase (42 U/!L),   
0.5 !L of Random 9-mers and 1.2 !L of total RNA (400 ng) were mixed. cDNA synthesis was 
performed in 1 cycle: 65 °C for 1 min, 30 °C for 1 min, gradually raise to 60-65 °C for 15 min, 98 °C 
for 5 min and 5 °C for 5 min. The amount of cDNA product was measured by a UV spectrophotometer 
(Beckman  coulter  DU800,  USA).  The  PCR  reaction  was  performed  with  Taq  PCR  MasterMix 
according to the manufacturer’s instruction: 2 !L of cDNA (1 !M), 1 !L of sense primer (10 !M),   
1 !L of antisense primer (10 !M), 12.5 !L of 2 ! Master Mix and 8.5 !L of ddH2O was added to the 
PCR tubes. The primer sequences were designed with Primer Premier 5.0 software. All primers were 
synthesized by Invitrogen (Shanghai, China). The primer pairs and the predicted sizes of the amplified 
PCR  products  and  the  PCR  annealing  temperatures  are  shown  in  Table  1.  The  PCR  conditions 
included  one  initial  denaturation  at  95 ° C   for  15  min,  followed  by  35  cycles  of  the  following 
conditions: 94 °C for 1 min, 50-65 °C for 30 s, 72 °C for 30 s and a final extension at 72 °C for 10 min. 
All PCR reactions were performed using a Bio-Rad Gradient Cycler (Bio-Rad PTC-200, USA). Eight 
microliters of PCR product was electrophoresed on 1% agarose gels, stained with SYBR Green I, and 
visualized  by  a  Bio-Rad  Gel  Imaging  System  (Bio-Rad  ChemiDoc  XRS,  USA).  The  gels  were 
analyzed by using Quantity One 1-D Analysis Software (Bio-Rad, USA). The relative quantities of 
gene  expression  were  presented  as  the  ratio  between  the  intensity  of  MOAP-1,  VEGF,  TRAF  6,   
CASP 2, E2F 1, CASP 5 band and that of the housekeeping gene #-actin. Int. J. Mol. Sci. 2010, 11                         
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Table 1. Primer sequences and annealing temperature of the genes in RT-PCR. 
Gene  Sense primer (5’-3’)  Antisense primer (5’-3’) 
Product 
size   
(bp) 
Annealing 
temperature 
(°C) 
MOAP-1  GAGTCTCAGGGAACCACGAAG  GGCACAGAAACGACAAAGGGC  155  60 
VEGF  CCCACTGAGGAGTCCAACA  CAAATGCTTTCTCCGCTCT  174  57 
TRAF6  CCTGTTGTGATTCATAGCC  GCATCCATTATCTCTTCGTG  242  55 
CASP2  TCCACCCCCACCACTCTTGACT  TGGCTTGCCTTCTTCCCTCTT  304  58 
E2F1  TACCCCAACTCCCTCTACC  TCTGTCTCCCTCCCTCACT  121  62 
CASP5  GTCTAAAGGACAAACCCAAGG  TGTGAAGAGATGAGTGCCAAG  109  57 
!–actin  TCATGAAGTGTGACGTGGACATC  TCTAGTTCTAGTAACGAGGAGGAC  156  60 
Six pro-apoptosis genes including MOAP-1, VEGF, TRAF 6, CASP 2, E2F 1 and CASP 5 were used to semi-quantitative RT-PCR analysis to confirm 
their expression in the microarray analysis, which were up-regulated more than 5-fold following FTY720 treatment in Jurkat cells in the microarray 
analysis. The primer pairs and the predicted sizes of the amplified PCR products and the annealing temperatures of PCR were listed. The primer sequences 
were designed with Primer Premier 5.0 software. !–actin is the housekeeping gene for the RT-PCR analysis. Int. J. Mol. Sci. 2010, 11                         
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3.7. Western Blotting Analysis 
Protein  levels  of  MOAP-1  and  VEGF  in  Jurkat  cells  treated  with  or  without  FTY720  were 
examined by Western blot. Cells (6 ! 10
6) were collected at 6 h after treatment with 10 !M FTY720 
and centrifuged at 450 g for 5 min at 4 °C. After washing with cold PBS, the cell pellet was lysed with 
extraction buffer (50 mM Tris-HCl, 150 mM NaCl, 1% NP-40, 0.25% NaDC, 1 mM EDTA, 1 mM 
PMSF,  1  mM  Na3VO4  and  10  !g/mL  aprotinin)  for  30  min  at  4  °C.  The  cell  lysate  was  then 
centrifuged a t  2,200  g  for  30  min,  and  the  supernatant  was  collected.  Protein  concentration  was 
determined by using a BCA protein assay kit. Thirty micrograms of denatured protein of each sample 
was  separated  by  12%  sodium  dodecyl  sulfatepolyacrylamide  gel  electrophoresis  (SDS-PAGE), 
transferred electrophoretically to polyvinylidene fluoride (PVDF) membranes, and blocked with 5% 
albumin  bovine  overnight.  The  membranes  were  incubated  with r abbit  anti-human M OAP-1 
polyclonal antibody (1:500 in TBST, TBST: 12.5 mM Tris/HCl, pH 7.6, 137 mM NaCl, 0.1% Tween 
20) or rabbit anti-human VEGF polyclonal antibody (1:1000 in TBST) for 2 h at room temperature. 
After washing with TBST for 3 times, the membranes were incubated with swine anti-rabbit IgG-HRP 
(1:2000) for 1 h at room temperature. The protein bands on the membranes were visualized by using 
enhanced chemiluminescence reagent according to the manufacturer’s instruction. A prestained protein 
marker was used as molecular weight marker. Equivalent protein loading and transfer efficiency were 
verified  by  staining  for  glyceraldehyde-3-phosphate  dehydrogenase  (GAPDH).  The  bands  were 
analyzed with a Bio-Rad Gel Imaging System (Bio-Rad ChemiDoc XRS, USA) and Quantity One 1-D 
Analysis Software (Bio-Rad, USA). 
3.8. Statistical Analysis 
Data were expressed as mean ± S.D. for the number of experiments indicated. All statistics were 
performed  using  SPSS  12.0  software.  Statistically  significant  differences  between  groups  were 
determined using a multivariate analysis of variance with post hoc test. Comparisons between two 
groups  were  performed  by  Student’s  t  test  for  parametric  data  and  Mann-Whitney  U t e s t  for 
nonparametric data. Correlation was calculated using Spearman’s non-parametric test. P < 0.05 was 
considered statistically significant. 
4. Conclusions 
In conclusion, FTY720 is capable of inducing Jurkat cell apoptosis. The signaling mechanism of 
FTY720-induced  apoptosis  is  most  likely  through  activation  of  mitochondria  signaling  pathways. 
Based on previous findings and our current results, we manage to draw a simplified diagram showing 
the potential signal transduction mechanisms of FTY720-induced apoptosis (Figure 6). Int. J. Mol. Sci. 2010, 11                         
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Figure  6.  Simple  diagram  of  FTY720  action  in  the  mitochondria  mediated  apoptotic 
pathway.  FTY720  up-regulated  the  expression  of  the  genes  MOAP-1,  Bax,  Smac  and 
Apaf-1, and down-regulated Bcl-2 expression.    shows activation.    shows inhibition.   
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